Cargando…
A Vaccine That Co-Targets Tumor Cells and Cancer Associated Fibroblasts Results in Enhanced Antitumor Activity by Inducing Antigen Spreading
Dendritic cell (DC) vaccines targeting only cancer cells have produced limited antitumor activity in most clinical studies. Targeting cancer-associated fibroblasts (CAFs) in addition to cancer cells may enhance antitumor effects, since CAFs, the central component of the tumor stroma, directly suppor...
Autores principales: | Gottschalk, Stephen, Yu, Feng, Ji, Minjun, Kakarla, Sunitha, Song, Xiao-Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861387/ https://www.ncbi.nlm.nih.gov/pubmed/24349329 http://dx.doi.org/10.1371/journal.pone.0082658 |
Ejemplares similares
-
Costimulation to enhance the antitumor activity of CD19 eng T cells
por: Velasquez, Mireya, et al.
Publicado: (2015) -
Targeting the tumor vasculature with TEM8-specific T cells
por: Williams, LaTerrica C, et al.
Publicado: (2014) -
Antitumor Cell-Complex Vaccines Employing Genetically Modified Tumor Cells and Fibroblasts
por: Miguel, Antonio, et al.
Publicado: (2014) -
HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity
por: Nguyen, Andrew, et al.
Publicado: (2022) -
Tumor Antigen-Dependent and Tumor Antigen-Independent Activation of Antitumor Activity in T Cells by a Bispecific Antibody-Modified Tumor Vaccine
por: Fournier, Philippe, et al.
Publicado: (2010)